EVALUATION OF CLINICAL SYMPTOMATOLOGY IN PATIENTS WITH HASHIMOTO'S ENCEPHALOPATHY AND ASSOCIATION WITH UNDERLING THYROID DISEASE

Objective: To determine the frequency of different neurological features in Hashimoto's encephalopathy and to evaluate association with underling disease. Study Design: Cross sectional study. Place and Duration of Study: A Three-year study from Jul 2015 to Jul 2018. Conducted in Pak Emira...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Asif Hashmat, Wasim Alamgir, Saeed Arif, Jahanzeb Liaqat
Formato: article
Lenguaje:EN
Publicado: Army Medical College Rawalpindi 2019
Materias:
R
Acceso en línea:https://doaj.org/article/bf5562c0886c4d32b96a296a45cbccd9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bf5562c0886c4d32b96a296a45cbccd9
record_format dspace
spelling oai:doaj.org-article:bf5562c0886c4d32b96a296a45cbccd92021-11-09T02:49:11ZEVALUATION OF CLINICAL SYMPTOMATOLOGY IN PATIENTS WITH HASHIMOTO'S ENCEPHALOPATHY AND ASSOCIATION WITH UNDERLING THYROID DISEASE0030-96482411-8842https://doaj.org/article/bf5562c0886c4d32b96a296a45cbccd92019-10-01T00:00:00Zhttps://www.pafmj.org/index.php/PAFMJ/article/view/3397/2372https://doaj.org/toc/0030-9648https://doaj.org/toc/2411-8842Objective: To determine the frequency of different neurological features in Hashimoto's encephalopathy and to evaluate association with underling disease. Study Design: Cross sectional study. Place and Duration of Study: A Three-year study from Jul 2015 to Jul 2018. Conducted in Pak Emirates Military Hospital (PEMH) Rawalpindi. Methodology: This study is comprised of diagnosed patients of Hashimoto's encephalopathy. These patients fulfilled the diagnostic criteria. Any case with metabolic, toxic, vascular or malignant etiology of encephalopathy was excluded. Data regarding clinical symptoms particularly neurological and neuropsychiatric features, of diagnosed cases with Hashimoto’s encephalopathy was obtained from hospital record. Moreover, data about antithyroid antibody type, cerebrospinal fluid analysis, and MRI findings was gathered. Gender and age of the patients were also mentioned. Data was gathered on proforma by a resident doctor. The analysis was carried out using SPSS 20. Results were mentioned in the form of the mean for variables like age and percentage and frequencies for categorical variables. Results: Out of 13 patients, 5 (38.5%) were male and 8 (61.5%) were females. Majority of the patients 8 (61.5%) were euthyroid. Neuropsychiatric symptoms were present in all 13 patients with depression present in 8 (61.5%) cases, while 5 (38.4%) had hallucinations. Most cases were cognitively normal 8 (61.5%), while rest had mild impairment. No neurological manifestation was found significantly more common in any of the thyroid disease. Migraine-like headaches was present in 4 (30.7%) cases while epileptic seizures were present in 8 (61.5%) patients with GTCS the most common seizures type in 3 (23%) patients. Only three patient had MRI changes including temporal and hippocampal T2WI hyperintensities. Conclusion: If etiological factors for encephalopathy has been ruled out in the presence of underlying thyroid disease with a short history of symptoms, one should have a low threshold for treatment with the steroid to observe for the response.Asif HashmatWasim AlamgirSaeed ArifJahanzeb LiaqatArmy Medical College Rawalpindiarticlehashimoto’s encephalopathynon-vasculitic autoimmune inflammatory meningoencephalitis (naim)MedicineRMedicine (General)R5-920ENPakistan Armed Forces Medical Journal, Vol 69, Iss 5, Pp 971-976 (2019)
institution DOAJ
collection DOAJ
language EN
topic hashimoto’s encephalopathy
non-vasculitic autoimmune inflammatory meningoencephalitis (naim)
Medicine
R
Medicine (General)
R5-920
spellingShingle hashimoto’s encephalopathy
non-vasculitic autoimmune inflammatory meningoencephalitis (naim)
Medicine
R
Medicine (General)
R5-920
Asif Hashmat
Wasim Alamgir
Saeed Arif
Jahanzeb Liaqat
EVALUATION OF CLINICAL SYMPTOMATOLOGY IN PATIENTS WITH HASHIMOTO'S ENCEPHALOPATHY AND ASSOCIATION WITH UNDERLING THYROID DISEASE
description Objective: To determine the frequency of different neurological features in Hashimoto's encephalopathy and to evaluate association with underling disease. Study Design: Cross sectional study. Place and Duration of Study: A Three-year study from Jul 2015 to Jul 2018. Conducted in Pak Emirates Military Hospital (PEMH) Rawalpindi. Methodology: This study is comprised of diagnosed patients of Hashimoto's encephalopathy. These patients fulfilled the diagnostic criteria. Any case with metabolic, toxic, vascular or malignant etiology of encephalopathy was excluded. Data regarding clinical symptoms particularly neurological and neuropsychiatric features, of diagnosed cases with Hashimoto’s encephalopathy was obtained from hospital record. Moreover, data about antithyroid antibody type, cerebrospinal fluid analysis, and MRI findings was gathered. Gender and age of the patients were also mentioned. Data was gathered on proforma by a resident doctor. The analysis was carried out using SPSS 20. Results were mentioned in the form of the mean for variables like age and percentage and frequencies for categorical variables. Results: Out of 13 patients, 5 (38.5%) were male and 8 (61.5%) were females. Majority of the patients 8 (61.5%) were euthyroid. Neuropsychiatric symptoms were present in all 13 patients with depression present in 8 (61.5%) cases, while 5 (38.4%) had hallucinations. Most cases were cognitively normal 8 (61.5%), while rest had mild impairment. No neurological manifestation was found significantly more common in any of the thyroid disease. Migraine-like headaches was present in 4 (30.7%) cases while epileptic seizures were present in 8 (61.5%) patients with GTCS the most common seizures type in 3 (23%) patients. Only three patient had MRI changes including temporal and hippocampal T2WI hyperintensities. Conclusion: If etiological factors for encephalopathy has been ruled out in the presence of underlying thyroid disease with a short history of symptoms, one should have a low threshold for treatment with the steroid to observe for the response.
format article
author Asif Hashmat
Wasim Alamgir
Saeed Arif
Jahanzeb Liaqat
author_facet Asif Hashmat
Wasim Alamgir
Saeed Arif
Jahanzeb Liaqat
author_sort Asif Hashmat
title EVALUATION OF CLINICAL SYMPTOMATOLOGY IN PATIENTS WITH HASHIMOTO'S ENCEPHALOPATHY AND ASSOCIATION WITH UNDERLING THYROID DISEASE
title_short EVALUATION OF CLINICAL SYMPTOMATOLOGY IN PATIENTS WITH HASHIMOTO'S ENCEPHALOPATHY AND ASSOCIATION WITH UNDERLING THYROID DISEASE
title_full EVALUATION OF CLINICAL SYMPTOMATOLOGY IN PATIENTS WITH HASHIMOTO'S ENCEPHALOPATHY AND ASSOCIATION WITH UNDERLING THYROID DISEASE
title_fullStr EVALUATION OF CLINICAL SYMPTOMATOLOGY IN PATIENTS WITH HASHIMOTO'S ENCEPHALOPATHY AND ASSOCIATION WITH UNDERLING THYROID DISEASE
title_full_unstemmed EVALUATION OF CLINICAL SYMPTOMATOLOGY IN PATIENTS WITH HASHIMOTO'S ENCEPHALOPATHY AND ASSOCIATION WITH UNDERLING THYROID DISEASE
title_sort evaluation of clinical symptomatology in patients with hashimoto's encephalopathy and association with underling thyroid disease
publisher Army Medical College Rawalpindi
publishDate 2019
url https://doaj.org/article/bf5562c0886c4d32b96a296a45cbccd9
work_keys_str_mv AT asifhashmat evaluationofclinicalsymptomatologyinpatientswithhashimotosencephalopathyandassociationwithunderlingthyroiddisease
AT wasimalamgir evaluationofclinicalsymptomatologyinpatientswithhashimotosencephalopathyandassociationwithunderlingthyroiddisease
AT saeedarif evaluationofclinicalsymptomatologyinpatientswithhashimotosencephalopathyandassociationwithunderlingthyroiddisease
AT jahanzebliaqat evaluationofclinicalsymptomatologyinpatientswithhashimotosencephalopathyandassociationwithunderlingthyroiddisease
_version_ 1718441420388302848